Home Isoray

Isoray

acquired
Post-IPO Round
Developer of Radiation Therapy Products
Basic
Enterprise Profile

Basic Information

Isoray is an innovative company dedicated to designing and developing the most advanced personalized brachytherapy products, which offer more cost-effective cancer treatments. With approximately 40 employees, Isoray focuses on introducing unique isotopes to treat both common and hard-to-treat cancers. Headquartered in Richland, under the shadow of the Hanford Nuclear Reservation, Isoray leverages regional expertise to develop proprietary processes for manufacturing the highly sought-after medical isotope Cesium-131, used in cancer brachytherapy. Brachytherapy is a technique that places radioactive sources ("seeds") as close as possible to the tumor site to destroy cancer cells. Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy sources, expanding treatment options for difficult-to-treat cancers. Isoray is committed to pioneering cost-effective solutions to bring life beyond cancer to patients.
Isoray Medical, Inc.
Washington,United States of America
15~50 people
January 01, 1998
--

Enterprise Profile

Industrial Sector
Therapeutic Manufacturing
Technology
Gene Technology Biotechnology
Concept
Disease Treatment Tumor
Application Scenarios
Medical Device Consumables